...
首页> 外文期刊>BMC Urology >Substance P induces localization of MIF/α1-inhibitor-3 complexes to umbrella cells via paracellular transit through the urothelium in the rat bladder
【24h】

Substance P induces localization of MIF/α1-inhibitor-3 complexes to umbrella cells via paracellular transit through the urothelium in the rat bladder

机译:P物质通过大鼠膀胱中的尿路上皮旁细胞迁移,诱导MIF /α1-inhibitor-3复合物定位于伞状细胞

获取原文
           

摘要

Background Macrophage migration inhibitory factor (MIF) is released into the intraluminal fluid during bladder inflammation in the rat complexed to α1-inhibitor-3 (A1-I3; a rodent proteinase inhibitor in the α-macroglobulin family). The location of A1-I3 in the bladder had not been investigated. Therefore, we examined the location of A1-I3 and MIF/A1-I3 complexes in the bladder and changes due to experimental inflammation. Methods Anesthetized male rats had bladders removed with no treatment (intact) or were injected with Substance P (SP; s.c.; saline vehicle). After one hour intraluminal fluid was removed, bladder was excised and MIF and A1-I3 levels were determined using ELISA and/or western-blotting. MIF co-immunoprecipitation determined MIF/A1-I3 complexes in the bladder. Bladder sections were immunostained for A1-I3 and MIF/A1-I3. Results A1-I3 immunostaining was observed in interstitial spaces throughout the bladder (including submucosa) but not urothelium in intact and saline-treated rats. RT-PCR showed that the bladder does not synthesize A1-I3, therefore, A1-I3 in the interstitial space of the bladder must be plasma derived. In SP-treated rats, A1-I3 in the bladder increased and A1-I3 was observed traversing through the urothelium. Umbrella cells that do not show MIF and/or A1-I3 immunostaining in intact or saline-treated rats, showed co-localization of MIF and A1-I3 after SP-treatment. Western blotting demonstrated that in the bladder MIF formed non-covalent interactions and also binds covalently to A1-I3 to form high molecular weight MIF/A1-I3 complexes (170, 130 and 75-kDa, respectively, verified by co-immunoprecipitation). SP-induced inflammation selectively reduced 170-kDa MIF/A1-I3 in the bladder while increasing 170 and 130-kDa MIF/A1-I3 in the intraluminal fluid. Conclusion A1-I3 and MIF/A1-I3 complexes are resident in bladder interstitium. During SP-induced inflammation, MIF/A1-I3 complexes are released from the bladder into the lumen. Binding of MIF/A1-I3 complexes to urothelial cells during inflammation suggests these complexes participate in the inflammatory reaction through activation of receptors for MIF and/or for A1-I3.
机译:背景巨噬细胞迁移抑制因子(MIF)在与α1-inhibitor-3(A1-I3;α-巨球蛋白家族中的啮齿动物蛋白酶抑制剂)复合的大鼠膀胱炎症期间释放到腔内液中。尚未调查A1-I3在膀胱中的位置。因此,我们检查了A1-I3和MIF / A1-I3复合物在膀胱中的位置以及由于实验性炎症引起的变化。方法麻醉的雄性大鼠未经治疗(完整)摘除膀胱或注射P物质(SP; s.c .;生理盐水)。一小时后,取出腔内液,切除膀胱,并使用ELISA和/或western-blotting测定MIF和A1-I3水平。 MIF免疫沉淀法测定了膀胱中的MIF / A1-I3复合物。对膀胱切片进行A1-I3和MIF / A1-I3免疫染色。结果在完整和生理盐水处理的大鼠中,在整个膀胱(包括粘膜下层)的间隙中观察到A1-I3免疫染色,而在尿路上皮中未观察到。 RT-PCR显示膀胱不能合成A1-I3,因此,膀胱间隙中的A1-I3必须是血浆来源的。在接受SP治疗的大鼠中,膀胱中的A1-I3升高,并且观察到A1-I3穿过尿道上皮。在完整或经盐水处理的大鼠中未显示MIF和/或A1-I3免疫染色的伞细胞在SP处理后显示MIF和A1-I3的共定位。蛋白质印迹表明,MIF在膀胱中形成非共价相互作用,并且也与A1-I3共价结合以形成高分子量MIF / A1-I3复合物(分别通过共免疫沉淀法验证为170、130和75 kDa)。 SP诱导的炎症选择性降低膀胱中的170 kDa MIF / A1-I3,同时增加腔内液中的170和130 kDa MIF / A1-I3。结论A1-I3和MIF / A1-I3复合物存在于膀胱间质中。在SP引起的炎症过程中,MIF / A1-I3复合物从膀胱释放到内腔。 MIF / A1-I3复合物在炎症过程中与尿道上皮细胞的结合表明这些复合物通过激活MIF和/或A1-I3受体参与炎症反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号